Proteomic Profiling of BRAFV600E Mutant Colon Cancer Cells Reveals the Involvement of Nucleophosmin/c-Myc Axis in Modulating the Response and Resistance to BRAF Inhibition by Vemurafenib

Petra Grbčić(University of Rijeka), Mirela Sedić(University of Rijeka)
International Journal of Molecular Sciences
June 8, 2021
Cited by 12


Related Papers